Combined oral contraceptive pills

PreclinicalSmall molecule

WWoman's Health University Hospital, Egypt

Combined oral contraceptive pills is one of 50 small molecule programs targeting Ovarian cyst. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Ovarian CystActive, not recruiting

EndometriosisActive, not recruiting

Ovarian CystPhase 2/Phase 3

Active, not recruiting

EndometriosisPreclinical

Active, not recruiting

Competition

Competitive Landscape

199 competitors in Endometriosis

#DrugCompanyPhaseTrials

Orilissa

AbbVie

Phase 3

16 2

Lupron

AbbVie

Phase 3

1 3

Revia

Teva

Phase 3

1 4

Leuprorelin

Takeda

Phase 3

8 5

Orgovyx

Sumitomo Pharma America, Inc.

Phase 3

3 6

Trental

VValidus Pharmaceuticals

Phase 3

1 7

Lupron

EEastern Cooperative Oncology Group

Phase 3

1 8

Firmagon

Ferring

Phase 3

1 9

Estradiol/norethindrone Acetate

AbbVie

Phase 3

5 10

Esketamine Hydrochloride

TThe Second Hospital of Anhui Medical University

Phase 3

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Endometriosis1 trial

Role of Medical Treatment in Endometriosis Patients Undergoing ICSI

Recruiting·—·N/A·NCT06577974·129 enrolled

Treatment1 trial

Treatment of Heavy and/or Prolonged Menstrual Bleeding Without Organic Cause

Completed·—·Phase 3·NCT02943655·240 enrolled

Ovarian cyst1 trial

Are the Combined Oral Contraceptive Pills Needed for Management of the Simple Ovarian Cysts in Reproductive Women?

Unknown status·—·Phase 2/3·NCT03357640·118 enrolled

Unspecified1 trial

Miniflare Versus Long Protocol in Poor Responders

Unknown status·WWoman's Health University Hospital, Egypt·N/A·NCT02681536·200 enrolled

Sources

References

[1]
ClinicalTrials.gov — 4 trial records for Combined oral contraceptive pills. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Combined oral contraceptive pills compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Combined oral contraceptive pills. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Woman's Health University Hospital, Egypt company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: WWoman's Health University Hospital, Egypt

Combined oral contraceptive pills

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Endometriosis1 trial

Treatment1 trial

Ovarian cyst1 trial

Unspecified1 trial

References

Drug Info

Quick Facts

Related News